SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kenneth J. Maxwell, M.D. who wrote (531)10/6/1997 9:24:00 PM
From: Bill Wexler   of 1728
 
I agree with you.

I think the technology is exciting and compelling.

However the bean counter in me has to measure risk vs. reward. I have seen many exciting technologies in the computer and biotech industries. Not all of them meant good returns for the early investors.

My guess is that if GeneChips and the associated test equipment generate the profits to match the hoopla, there will be many, many opportunities to buy this stock in the future at much more reasonable prices.

I would feel a lot more comfortable at the current price if Affymax had hung on a little longer before spinning off Affymetrix. Why are small investors bearing the brunt of the risk now?

This company was very well capitalized about 5 or 600 million dollars ago. It looks like it has become a momentum stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext